Medicine for resisting pressure overload myocardial hypertrophy and ventricular remodeling and application

A technique for ventricular remodeling and myocardial hypertrophy, which is applied in the drug and application of ventricular remodeling, in the field of anti-pressure overload myocardial hypertrophy, and can solve problems such as no research on leonurine.
CN112773784AInactive Publication Date: 2021-05-11贵州中医药大学
1 Cites 3 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
贵州中医药大学
Publication Date
2021-05-11
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention belongs to the technical field of biological pharmacy, and discloses a medicine for resisting pressure overload myocardial hypertrophy and ventricular remodeling and application. The application comprises the following steps of: establishing a pressure overload rat myocardial hypertrophy and ventricular remodeling animal model by adopting abdominal aorta constriction; constricting the abdominal aorta for 28d, and sequentially detecting the change of a hemodynamic index and the diameter of a myocardial cell; and transecting the left ventricular myocardial tissue of a rat, observing the form of the myocardial cell under an optical microscope after conventional HE staining, and observing the change effect of leonurine on the pathological form of the left ventricular myocardial tissue of the rat. The invention proves that high and low dosage groups of leonurine have a certain improvement effect on cardiac diastolic and systolic dysfunction of a myocardial hypertrophy rat induced after abdominal aorta constriction; the high and low dosage groups of leonurine can reduce the left ventricular hypertrophy index of the rat after AAC operation; and the high and low dosage groups of leonurine and a positive group can inhibit myocardial cell hypertrophy of the rat after AAC operation and inhibit ventricular remodeling.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the technical field of biopharmaceuticals, and in particular relates to a drug for resisting pressure overload myocardial hypertrophy and ventricular remodeling and its application. Background technique

[0002] At present, the closest prior art: Cardiac hypertrophy is a common pathophysiological change in various cardiovascular diseases such as hypertension, coronary heart disease, heart valve disease, congenital heart disease, and cardiomyopathy, and is a key factor in cardiac function. The evolution from the compensatory period to the decompensated period is a key stage in the development of cardiac structure from reversible change to irreversible change, and is an important pathophysiological basis of heart failure. Pressure overload induces myocardial hypertrophy and ventricular remodeling is one of the main reasons. Leonurine is one of the extracts of the traditional Chinese medicine Motherwort, which has the effect of i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More